BLS Pharmaceuticals Limited (ASX:BLS)

Australia · Delayed Price · Currency is AUD

1.040

+0.025 (2.46%)

Oct 13, 2026, 4:10 PM AEST

Revenue by Segment

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017
Wholesale - PCC/USA	554.87K	700.92K	886.91K	42.56K	-
Plant Based - UK/EU/JPN/AUS	2.47M	3.05M	5.44M	5.11M	463.64K
Manufacture/sales - Australia	71.14M	24.68M	3.00M	-	-
Unallocated	-	872.96K	334.10K	182.04K	4.73K
Total	74.16M	29.30M	9.66M	5.34M	468.37K

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017
Australia	71.69M	25.35M	-	-	-
United Kingdom	1.08M	888.81K	-	-	-
Europe	1.19M	1.69M	-	-	-
Japan	199.53K	497.48K	-	-	-
Total	74.16M	28.43M	-	-	-